DBITE
LIVE

Serial Number

97341385

Owner

Amgen Research (Munich) GmbH

Attorney

Elsa D. Lemoine

Filing Date

Mar 31, 2022

Add to watchlist:

No watchlists yet
View on USPTO

DBITE Trademark

Serial Number: 97341385

DBITE is a trademark filed by Amgen Research (Munich) GmbH on March 31, 2022. The trademark is classified under Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 42 (Computer & Scientific), Class 16 (Paper Goods), Class 35 (Advertising & Business). The application is currently pending registration.

Owner Contact Info

Amgen Research (Munich) GmbH (2 trademarks)

Munich 81477 , DE

Entity Type: 16

Trademark Details

Filing Date

March 31, 2022

Registration Date

Not Registered

Published for Opposition

April 25, 2023

Goods & Services

Medicaments, namely, polypeptides, for use in the treatment of tumorous diseases, cancer, allergies, autoimmunity, inflammation, osteoporosis, graft versus host diseases, transplant rejection, cardiovascular diseases, metabolic diseases, neurological diseases, and minimal residual diseases

Providing medical and scientific research information regarding therapeutic polypeptides and use thereof; providing a website featuring medical and scientific research information regarding antibody derivatives and use thereof; providing scientific information regarding antibody derivatives and use thereof; providing a website featuring scientific information regarding antibody derivatives and use thereof

Promoting interest, namely, promoting the interests of healthcare practitioners, and promoting awareness, namely, advertising in the nature of promoting the goods of others to healthcare practitioners and the public regarding therapeutic polypeptides and use thereof; promoting education for healthcare professionals on health and medical issues, namely, therapeutic polypeptides and use thereof

Downloadable educational materials, namely, video recordings, books, and printable booklets on therapeutic polypeptides and use thereof

Printed educational materials on therapeutic polypeptides and use thereof; printed educational materials in the field of therapeutic polypeptides and use thereof

Filing History

SOU TEAS EXTENSION RECEIVED
Dec 8, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 15, 2025 EXRA
SOU EXTENSION 4 GRANTED
May 15, 2025 EX4G
SOU EXTENSION 4 FILED
May 14, 2025 EXT4
SOU TEAS EXTENSION RECEIVED
May 14, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 25, 2024 EXRA
SOU EXTENSION 3 GRANTED
Oct 25, 2024 EX3G
SOU EXTENSION 3 FILED
Oct 25, 2024 EXT3
SOU TEAS EXTENSION RECEIVED
Oct 25, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 26, 2024 EXRA
SOU EXTENSION 2 GRANTED
Apr 25, 2024 EX2G
SOU EXTENSION 2 FILED
Apr 25, 2024 EXT2
SOU TEAS EXTENSION RECEIVED
Apr 25, 2024 EEXT
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Dec 1, 2023 EWAF
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Dec 1, 2023 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Dec 1, 2023 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Dec 1, 2023 REAP
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Dec 1, 2023 EXRA
SOU EXTENSION 1 GRANTED
Nov 30, 2023 EX1G
SOU EXTENSION 1 FILED
Nov 30, 2023 EXT1
SOU TEAS EXTENSION RECEIVED
Nov 30, 2023 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jun 20, 2023 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 25, 2023 NPUB
PUBLISHED FOR OPPOSITION
Apr 25, 2023 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 5, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 21, 2023 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 15, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 14, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 14, 2023 TROA
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Mar 14, 2023 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 14, 2023 TCCA
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Mar 14, 2023 EWAF
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Mar 14, 2023 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Mar 14, 2023 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Mar 14, 2023 COAR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jan 17, 2023 GNRN
NON-FINAL ACTION E-MAILED
Jan 17, 2023 GNRT
NON-FINAL ACTION WRITTEN
Jan 17, 2023 CNRT
ASSIGNED TO EXAMINER
Jan 17, 2023 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 6, 2022 NWOS
NEW APPLICATION ENTERED
Apr 4, 2022 NWAP